Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
86.8M
-
Shares change
-
+20.7M
-
Total reported value, excl. options
-
$477M
-
Value change
-
+$124M
-
Put/Call ratio
-
0.53
-
Number of buys
-
126
-
Number of sells
-
-54
-
Price
-
$5.49
Significant Holders of Xeris Biopharma Holdings, Inc. - COM (XERS) as of Q1 2025
220 filings reported holding XERS - Xeris Biopharma Holdings, Inc. - COM as of Q1 2025.
Xeris Biopharma Holdings, Inc. - COM (XERS) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 86.8M shares
.
Largest 10 shareholders include BlackRock, Inc. (10.8M shares), VANGUARD GROUP INC (8.11M shares), MORGAN STANLEY (4.29M shares), GEODE CAPITAL MANAGEMENT, LLC (3.41M shares), STATE STREET CORP (3.33M shares), D. E. Shaw & Co., Inc. (3.05M shares), GOLDMAN SACHS GROUP INC (2.79M shares), Rosalind Advisors, Inc. (2.5M shares), MILLENNIUM MANAGEMENT LLC (2.32M shares), and Nuveen, LLC (2.23M shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.